Motivations for Using MDMA (Ecstasy/Molly) among African Americans: Implications for Prevention and Harm-Reduction Programs [0.03%]
美国非裔人群使用MDMA（摇头丸/慕丽）的动机以及对预防和减少伤害项目的启示
Khary K Rigg
Khary K Rigg
Despite the growing popularity of MDMA (ecstasy/molly) among African Americans, their motives for using the drug are still largely unknown. The purpose of this study was to identify and describe the most salient motivations for using MDMA a...
Massachusetts Substance Use Disorder Treatment Organizations' Perspectives on the Affordable Care Act: Changes in Payment, Services, and System Design [0.03%]
美国马萨诸塞州物质使用障碍治疗组织对《平价医疗法案》的看法：支付方式、服务和系统设计的变化
Amity E Quinn,Maureen T Stewart,Mary Brolin et al.
Amity E Quinn et al.
The Affordable Care Act (ACA) expanded insurance benefits and coverage for substance use disorder (SUD) treatment and encouraged delivery and payment reforms. Massachusetts passed a similar reform in 2006. This study aims to assess Massachu...
Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014 [0.03%]
美国商业健康保险计划中针对阿片类药物使用障碍的特定治疗方法的报销情况（2003-2014）
Sharon Reif,Timothy B Creedon,Constance M Horgan et al.
Sharon Reif et al.
Opioid use disorders (OUDs) are receiving significant attention in the U.S. as a public health crisis. Access to treatment for OUDs is essential and was expected to improve following implementation of the federal parity law and the Affordab...
Integration of Care in the Implementation of the Affordable Care Act: Changes in Treatment Services in a National Sample of Centers Treating Substance Use Disorders [0.03%]
平价医疗法案执行中的治疗整合：一项全国范围内的物质使用障碍治疗机构服务变化调查研究
Lydia Aletraris,Paul M Roman,Jana Pruett
Lydia Aletraris
This study examined patterns of medicalization in substance use disorder (SUD) that are aligned with the goals of the Affordable Care Act (ACA). Using a nationally representative sample of SUD treatment programs, we examined changes in seve...
Relationships between a Dissociative Subtype of PTSD and Clinical Characteristics in Patients with Substance Use Disorders [0.03%]
substance use障碍患者中PTSD分离亚型与其临床特征的关系
Michaela Mergler,Martin Driessen,Christel Lüdecke et al.
Michaela Mergler et al.
The increasing support for a dissociative subtype of post-traumatic stress disorder (PTSD-D) has led to its inclusion in DSM-5. We examined relationships between PTSD-D and relevant variables in patients with substance use disorders (SUD). ...
The Addiction Benefits Scorecard: A Framework to Promote Health Insurer Accountability and Support Consumer Engagement [0.03%]
依赖益处记分牌：促进健康保险商承担责任和消费者参与的框架
Itai Danovitch,David Kan
Itai Danovitch
Health care insurance plans covering treatment for substance use disorders (SUD) offer a wide range of benefits. Distinctions between health plan benefits are confusing, and consumers making selections may not adequately understand the char...
A Social Work Response to the Affordable Care Act: Prevention and Early Intervention [0.03%]
美国平价医疗法案下的社会工作回应：防治与早期干预
Matthew J Corrigan,Kathryn Krase,John Charles Reed
Matthew J Corrigan
The Patient Protection and Affordable Care Act represents a reinvestment in primary care, with a focus on prevention of illness and remediation of the impacts of chronic diseases through a behavioral health framework. Licensed social work p...
Medicalizing the Opioid Epidemic in the U.S. in the Era of Health Care Reform [0.03%]
美国医疗改革时代的医疗化 opioid 流行病
David E Smith
David E Smith
The medicalization of the current opioid epidemic in the era of health care reform and parity, and its possible dismantling, poses many challenges. Between 2002 and 2013, drug overdose rates quadrupled. Parallel to an increase in prescripti...
Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers [0.03%]
美国Affordable Care Act实施后丁丙诺啡处方医生的感知影响分析
Hannah K Knudsen,Jamie L Studts
Hannah K Knudsen
The Affordable Care Act (ACA) has been heralded as a major policy change that is expected to transform the delivery of substance use disorder (SUD) treatment. Few studies have reported on the perceived impacts of ACA from the perspectives o...
The Blue Lotus Flower (Nymphea caerulea) Resin Used in a New Type of Electronic Cigarette, the Re-Buildable Dripping Atomizer [0.03%]
埃及蓝莲花（Nymphaea caerulea）树脂在新型电子烟 rebuildable dripping atomizer 中的使用
Justin L Poklis,Haley A Mulder,Matthew S Halquist et al.
Justin L Poklis et al.
The blue lotus flower (Nymphea caerulea) is an Egyptian water lily containing apomorphine and nuciferine. Apomorphine has been described as a psychoactive alkaloid and is a non-selective dopamine agonist primarily used to treat Parkinson's ...